Pharma is in focus but there is no valuation comfort: Prabhudas Lilladher – Economic Times

‘We have a buy on Dr Reddys and Lupin. Dr Reddys definitely has a positive but the valuation remains very challenging after this recent run up of Rs 1,000 or more.

powered by Advanced iFrame free. Get the Pro version on CodeCanyon.

Leave a Reply

Your email address will not be published. Required fields are marked *